The Ketek saga continues as a former employee of Pharmaceutical
Product Development (PPD) has claimed that Aventis and PPD – the
contract research organisation (CRO) hired by the firm – were both
aware of fraudulent data in a clinical...
US outsourcing company Covance has announced it is to open a
central laboratory in China in order to meet the growing demand for
clinical trials conducted in the region and has expanded its
capabilities in Texas.
Hesperion has opened a Russian arm of its contract research
business in a bid to 'increase its attractiveness' to clinical
trial sponsors requiring large patient populations.
Parexel has announced encouraging financial results for its second
fiscal quarter, despite 'disappointing' performance in its medical
communications business.
PRA International has entered into an alliance with US Oncology
Research, designed to accelerate the clinical development of new
cancer treatments in the US.
Charles River Laboratories confirmed it is persevering in its
intention to focus on its preclinical and Phase I businesses while
abandoning its late stage development services, during a conference
earlier this month.
The move towards electronic files is set to bring major benefits in
the clinical trials area especially in terms of patient
recruitment, new research suggests.
There are currently three key market trends that play to Parexel's
strengths and one of them is the globalisation of clinical trials,
the company's CEO claimed during a healthcare conference earlier
this month.
Covance was nothing but optimistic about the future of contract
research organisations (CROs) during a JPMorgan healthcare
conference held last week, despite a slowdown in R&D spending
over the past year.
Two companies have gone a step further to capture a bigger chunk of
the budding eClinical market by offering a new integrated solution
for pharma companies who continue to move away from paper toward
electronic reporting in clinical...
Quintiles has teamed up with practices group Onmark to create a
national clinical trial network comprised of Onmark members - a
move that could help the CRO cope with increasing patient
recruitment issues in the US.
China is now an industry buzzword when it comes to outsourcing and
yet another report adds to the list of research recently published
that give evidence of the increasing popularity of the country as a
location to conduct drug clinical...
A new clinical research tool is now available, offering
investigators the ability to integrate clinical data from a number
of different sources across the clinical development spectrum.
Singapore is planning to double the number of clinical trials it
runs over the next five year, particularly in early phase research,
as it looks to hold its ground amidst industry explosion in the
Asia Pacific.
MDS has announced it will help its customers confirm or repeat
analyses done at its contract research facilities in Quebec, after
the Food and Drug Administration (FDA) urged some drug makers to
retest products because of concerns...
The nature of patient compliance as the weak link in controlling
clinical trials is set to drive the growing interest of drug
developers and in particular contract research organisations (CROs)
for new technologies that improve compliance,...
Helix BioPharma and BioVectra have signed a deal for the
manufacture of Helix's new lung cancer drug for clinical trials - a
move that strengthens the already existing relationship between the
two Canadian firms.
Despite the many challenges facing the pharma industry, drug
developers should be optimistic, and one of the reasons is the
increasing reliance on global outsourcing to speed development and
reduce costs, says new report.
DSM Pharmaceuticals is showing no sign of slowing down as it
continues to invest in the expansion of its pharmaceutical
production capabilities - the latest being the completion of a
revamped sterile parenteral manufacturing plant...
Encorium Group has bagged a $12.4m multi-year contract from a
mystery biopharma firm to conduct a Phase III drug trial for
prostate cancer - the most common cancer in men.
Quintiles has formed a new alliance with a hospital near its
headquarters in North Carolina, from where it has begun running
clinical trials on experimental drugs.
Ciphergen has hired contract research organization (CRO)
PrecisionMed to help it with upcoming clinical trials for its
experimental ovarian cancer tests.
In the next one to two years there will be a trend towards
significant reductions in clinical outsourcing/contract research
organisation (CRO) budgets in the majority of biopharma firms,
reveals a recent industry survey.
MDS has been heavily impacted by a US Food and Drug Administration
procedural review of its bioanalytical operations, but still
managed to report quarterly earnings of C$53m (€35m).
i3 has announced new plans to expand its pharmaceutical services
offerings across four continents - India, Latin America, and
Eastern and Western Europe.
The US Senate has confirmed Andrew von Eschenbach as the official
Commissioner of the Food and Drug Administration (FDA) after months
of delay due to complaints about the regulator's oversight.
Galapagos is to spend up to €19.1m to acquire Inpharmatica in order
to accelerate their drug discovery capabilities, especially in the
early stages of development.
Before deciding what part of a clinical trial to outsource, one of
the most important things a sponsor should do is define its core
competencies and then outsource accordingly.
The contract research organisation (CRO) industry is in full swing
as the clinical trial outsourcing trend continues, but where is the
money being spent?
A new contract research organization (CRO) has opened in Hong Kong
and will be the only clinical trial site outside of China with the
approval of China's State Food and Drug Administration (SFDA) to
run oncology trials.
It has been another few weeks of activity for the budding eClinical
industry as sponsors across the globe continue to move away from
paper toward electronic reporting in clinical trials.
Charles River Laboratories is the latest in a series of large
contract research organisations making acquisitions to beef up
their Phase I capacity as this market sector remains hot.